BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has announced a change in their Director Jayne Shaw’s interest in the company’s securities, with Shaw acquiring an additional 125,000 ordinary shares for $14,375 through an on-market purchase. This transaction has increased Shaw’s total number of shares held in the company, although the Director has not disposed of any shares in this process.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
